OBJECTIVE: To determine the prevalence of @entity43 in @entity43 . STUDY DESIGN: A retrospective analysis of 160 malignant and 23 borderline @entity43 during the period 1995-2001. RESULTS: Fourteen (7.7%) of the @entity5 contained @entity46 . This affected 22% of the endometrioid and 10.8% of the mixed @entity420 . The mean age of the @entity43 @entity1 was 43+/-13 range 26-70 years. The incidence in borderline @entity5 13% (3/23) was higher than that in @entity43 6.9% (11/160) (P>0.05). Eight (57%) of cases were classified as atypical and six (43%) as typical @entity46 . Nine cases were FIGO (International Federation of Gynaecology and Obstetrics) stage I and 5 stage III. CONCLUSIONS: Both @entity43 are associated with @entity43 . In addition, atypical @entity46 was found associated with endometrioid and mixed @entity43 .

Prevalence of @entity46 in XXXX .

@entity43 :: ('MESH:D010051', 'Disease') :: ['malignant epithelial ovarian tumours', 'ovarian endometriosis', 'epithelial ovarian tumours', 'ovarian cancer', 'malignant and borderline ovarian tumours', 'ovarian tumours'] @entity1 :: ('9606', 'Species') :: ['patients'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumours'] @entity46 :: ('MESH:D004715', 'Disease') :: ['endometriosis'] @entity420 :: ('MESH:D000230', 'Disease') :: ['adenocarcinomas']
@entity5 :: (MESH:D009369,Disease) :: ['malignant epithelial ovary tumours']
